{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Metabolic Dysfunction--Associated Steatotic Liver Disease: Emerging Risk Factors for Adverse Pregnancy Outcomes

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the negative health impacts of MASLD in pregnancy on both mother and infant.
  2. Explain the importance of screening women for MASLD before or early pregnancy, irrespective of their BMI, especially if deemed at risk.
  3. Discuss strategies to reduce adverse pregnancy outcomes and enhance health outcomes for mothers and offspring.
Price: $30.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: CLD0224A
Published: February 2024
Expires: 1/31/2026
Required Passing Score: 3/4 (75%)
Authors: Georgia Sofia Karachaliou and Ayako Suzuki
Categories: Hepatology
Specialties: Hepatology
Topics: MASLD